These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11374665)

  • 21. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Helicobacter pylori infection. Triple regimen based on ranitidine bismuth citrate could be solution.
    Savarino V; Neri M; Vigneri S
    BMJ; 2000 Jun; 320(7248):1541. PubMed ID: 10877585
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay].
    Cuena Boy R
    An Med Interna; 2002 Aug; 19(8):439-40; author reply 440. PubMed ID: 12244799
    [No Abstract]   [Full Text] [Related]  

  • 25. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
    Bujanda L; Sánchez A; Iriondo C; Santos A; Cosme A; Muñoz C
    An Med Interna; 2001 Jul; 18(7):361-3. PubMed ID: 11534420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
    Marini RP; Fox JG; Taylor NS; Yan L; McColm AA; Williamson R
    Am J Vet Res; 1999 Oct; 60(10):1280-6. PubMed ID: 10791942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment for H. pylori infection: new challenges with antimicrobial resistance.
    Vakil N; Vaira D
    J Clin Gastroenterol; 2013; 47(5):383-8. PubMed ID: 23388847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies for Helicobacter pylori infection.
    Marshall BJ
    Gastroenterol Clin North Am; 1993 Mar; 22(1):183-98. PubMed ID: 8449566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.
    Graham DY; de Boer WA; Tytgat GN
    Am J Gastroenterol; 1996 Jun; 91(6):1072-6. PubMed ID: 8651150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs?
    Nijevitch AA; Farztdinov KM; Sataev VU; Dashkova S; Kazykhanov NS
    Am J Gastroenterol; 2001 Mar; 96(3):921-2. PubMed ID: 11280584
    [No Abstract]   [Full Text] [Related]  

  • 35. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.
    Gisbert JP; Pajares JM; Valle J
    Helicobacter; 1999 Mar; 4(1):58-66. PubMed ID: 10352089
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of Helicobacter pylori.
    Selgrad M; Malfertheiner P
    Curr Opin Gastroenterol; 2011 Oct; 27(6):565-70. PubMed ID: 21946029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The attitude in a failure to eradicate Helicobacter pylori: surrender or fight?].
    Gisbert JP
    Med Clin (Barc); 1998 Dec; 111(20):778-82. PubMed ID: 9922969
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment after failure: the problem of "non-responders".
    Huang JQ; Hunt RH
    Gut; 1999 Jul; 45 Suppl 1(Suppl 1):I40-4. PubMed ID: 10457036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis.
    Wu C; Chen X; Liu J; Li MY; Zhang ZQ; Wang ZQ
    Helicobacter; 2011 Apr; 16(2):131-8. PubMed ID: 21435091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating Helicobacter pylori.
    Katelaris PH
    Aust Fam Physician; 1999 Oct; 28(10):1026-9. PubMed ID: 10592580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.